Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | 8-K:Milestone Pharmicals公佈2024年第一季度財務業績並提供監管和公司最新情況
Milestone Pharmaceuticals | 10-Q:季度報表
Milestone Pharmaceuticals | 10-K/A:年度報表(修正版)
Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | 8-K:Milestone Pharmicals公佈2023年第四季度和全年財務業績,並提供監管和公司最新情況
Milestone Pharmaceuticals | 10-K:年度報表
Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | 424B5:募資說明書
Milestone Pharmaceuticals | 424B5:募資說明書
Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(2.8%),VHCP Co-Investment Holdings III, LLC(2.8%)等
Milestone Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
Milestone Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(4.1 %),GOLDMAN SACHS & CO. LLC(4.1 %)
Milestone Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Integrated Core Strategies (US) LLC(5.2%),Millennium Management LLC(5.2%)等
Milestone Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(9.8%)
Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | 8-K:Milestone Pharmicals公佈2023年第三季度財務業績並提供臨床和企業最新情況
Milestone Pharmaceuticals | 8-K:重大事件
暫無數據